Compound ID | 1261
Class: Lipopolysaccharide synthesis inhibitor (LpxC inhibitor)
| Spectrum of activity: | Gram-negative |
| Details of activity: | Activity against Gram-negative pathogens including multidrug resistant. |
| Institute where first reported: | Dong-A ST Pharm |
| Highest developmental phase: | Preclinical |
| Development status: | Active |